Last updated: July 17, 2026

Application No. 19/083,627

HEMOSTATIC COMPOSITIONS AND RELATED METHODS

Non-Final OA

Filed

Mar 19, 2025

Priority

Apr 17, 2020 — provisional 63/011,492 +1 more

Examiner

WISTNER, SARAH CLINKSCALES

Art Unit

1616

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Boston Scientific Scimed Inc.

OA Round

1 (Non-Final)

This examiner grants 18% of cases after interview

— +69.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 22 resolved cases, 2023–2026

Examiner Intelligence

WISTNER, SARAH CLINKSCALES View full profile →

Grants only 18% of cases

Career Allowance Rate

4 granted / 22 resolved

-41.8% vs TC avg

Strong +69% interview lift

Without

With

+69.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

42 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

38.0%

-2.0% vs TC avg

§102

6.0%

-34.0% vs TC avg

§112

2.3%

-37.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 22 resolved cases

Prosecution Timeline

Mar 19, 2025

Application Filed

May 04, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/250,589

Patent 12653186

[(1-PHENYL-5-(HETEROARYL)-1H-1,2,4-TRIAZOL-3-YL)OXY] ACETIC ACID DERIVATIVES AS SAFENERS FOR THE PROTECTION OF USEFUL PLANTS AND CROP PLANTS

3y 1m to grant Granted Jun 16, 2026

17/739,090

Patent 12343434

Hybrid membrane camouflaged nanomedicine loaded with oxidative phosphorylation inhibitor and preparing method thereof

3y 1m to grant Granted Jul 01, 2025

17/264,832

Patent 12329162

Methods for Enhancing Root Strength and Safety of Turf Grass

4y 4m to grant Granted Jun 17, 2025

17/233,101

Patent 12285539

HEMOSTATIC COMPOSITIONS AND RELATED METHODS

4y 0m to grant Granted Apr 29, 2025

Study what changed to get past this examiner. Based on 4 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

18%

Grant Probability

88%

With Interview (+69.4%)

3y 4m (~2y 0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 22 resolved cases by this examiner. Grant probability derived from career allowance rate.

HEMOSTATIC COMPOSITIONS AND RELATED METHODS

This examiner grants 18% of cases after interview

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email